Immuno-Oncology II: Next Wave IO Targets and Modalities

Wednesday, March 9, 2016
10:45 – 12:00pm

Immuno-Oncology II: Next Wave IO Targets and Modalities

Moderator:

  • Jeffrey M. Bockman, PhD,  Vice President, Defined Health.

Panelists:

  • Kenneth Carter, PhD, President and Chief Executive Officer, NexImmune
  • Alessandra Cesano, MD, PhD, Chief Medical Officer, NanoString Technologies
  • Thomas Gajewski, MD, PhD, Professor of Medicine, University of Chicago
  • Rachel W. Humphrey, MD, Chief Medical Officer, CytomX Therapeutics, Inc.
  • Christopher Lengauer, PhD, MBA, Chief Scientific Officer, Blueprint Medicines
  • Peter Sandor, MD, MBA, VP, Head of Oncology Therapeutic Area in Marketing Strategy, Astellas Pharma

Register-Button-green